Protease Resistant Growth Factor Formulations for Chronic Wound Healing
- Detailed Technology Description
- Our inventors have derived a novel formulation that fuses elastase resistant peptide PMP-D2 variant to a bioactive protein, a fusion that retains the biological activities of the moieties and will preserve the bioactivity of different growth factors and functional peptide in chronic wounds.
- *Abstract
-
Researchers at the University of South Florida have derived protease resistant growth factor formulations for chronic woundhealing.
- Country/Region
- USA
For more information, please click Here
